World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
100
Citations
37292
World Ranking
8261
National Ranking
118

Overview

Anna Sureda is affiliated with the Autonomous University of Barcelona in Spain and has an extensive publication record in the field of medicine, with a specific focus on oncology, hematology, and related subfields. Their research contributions include 917 publications in medicine, with notable emphasis on oncology (282 publications), hematology (162), pathology and forensic medicine (157), molecular biology (83), and genetics (73).

Sureda's main research topics cover a range of hematological malignancies and therapies, including:

  • CAR-T cell therapy research
  • Lymphoma diagnosis and treatment
  • Multiple myeloma research and treatments
  • Chronic lymphocytic leukemia research
  • Hematopoietic stem cell transplantation
  • Monoclonal and polyclonal antibodies research
  • Protein degradation and inhibitors

The scientist's recent papers include:

  • "Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma" (2021), New England Journal of Medicine
  • "Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma" (2022), New England Journal of Medicine
  • "Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma" (2021), New England Journal of Medicine
  • "Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma" (2023), New England Journal of Medicine
  • "Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial" (2021), Journal of Clinical Oncology

Sureda frequently publishes in the following venues:

  • Blood (93 publications)
  • Clinical Lymphoma Myeloma & Leukemia (40 publications)
  • Bone Marrow Transplantation (39 publications)
  • Hematological Oncology (38 publications)
  • Journal of Clinical Oncology (21 publications)

Their collaboration network includes frequent co-authors such as Alberto Mussetti (62 joint publications), Albert Oriol (56), María-Victoria Mateos (49), Joaquin Martínez-López (47), and Jesús F. San Miguel (46).

Best Publications

  • Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial

    Craig H. Moskowitz;Auayporn Nademanee;Tamas Masszi;Edward Agura

  • Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

    Steven Horwitz;Owen A O'Connor;Barbara Pro;Tim Illidge

  • Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually

    Jakob Passweg;H. Baldomero;P. Bader;Chiara Bonini

  • Allogeneic bone marrow transplantation versus autologous stem cell transplantation in multiple myeloma: a retrospective case-matched study from the European Group for Blood and Marrow Transplantation

    BB Bjorkstrand;P Ljungman;H Svensson;J Hermans

  • Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation.

    Bruno Paiva;Maria-Belén Vidriales;Jorge Cerveró;Gema Mateo

  • Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009.

    P. Ljungman;M. Bregni;M. Brune;J. Cornelissen

  • Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015

    A. Sureda;P. Bader;S. Cesaro;P. Dreger

  • Reduced-Intensity Conditioning Compared With Conventional Allogeneic Stem-Cell Transplantation in Relapsed or Refractory Hodgkin's Lymphoma: An Analysis From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

    Anna Sureda;Stephen Robinson;Carmen Canals;Angelo M. Carella

  • Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.

    Alois Gratwohl;Martin Stern;Ronald Brand;Jane Apperley

  • Influence of Pre- and Post-Transplantation Responses on Outcome of Patients With Multiple Myeloma: Sequential Improvement of Response and Achievement of Complete Response Are Associated With Longer Survival

    Juan José Lahuerta;Maria Victoria Mateos;Joaquin Martínez-López;Laura Rosiñol

  • Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

    T. Ruutu;A. Gratwohl;T. De Witte;B. Afanasyev

  • High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma

    Bruno Paiva;Norma C. Gutiérrez;Laura Rosiñol;María-Belén Vídriales

  • Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell-Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial

    Martin Hutchings;Franck Morschhauser;Gloria Iacoboni;Carmelo Carlo-Stella

  • A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma.

    Laura Rosiñol;José Antonio Pérez-Simón;Anna Sureda;Javier de la Rubia

  • Autologous Stem-Cell Transplantation for Hodgkin’s Disease: Results and Prognostic Factors in 494 Patients From the Grupo Español de Linfomas/Transplante Autólogo de Médula Ósea Spanish Cooperative Group

    A Sureda;R Arranz;A Iriondo;E Carreras

  • Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

    S. K. Kumar;M. A. Dimopoulos;E. Kastritis;E. Terpos

  • Panobinostat in Patients With Relapsed/Refractory Hodgkin's Lymphoma After Autologous Stem-Cell Transplantation: Results of a Phase II Study

    Anas Younes;Anna Sureda;Dina Ben-Yehuda;Pier Luigi Zinzani

  • Waldenström macroglobulinaemia: presenting features and outcome in a series with 217 cases

    Ramón García‐Sanz;Silvia Montoto;Agustín Torrequebrada;Alfonso García De Coca

  • Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors.

    Abraham S. Kanate;Alberto Mussetti;Mohamed A. Kharfan-Dabaja;Kwang W. Ahn;Kwang W. Ahn

  • Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe

    A. Urbano-Ispizua;N. Schmitz;T.J.M. de Witte;F. Frassoni

Frequent Co-Authors

Rodrigo Martino
Rodrigo Martino Hospital de Sant Pau
Juan José Lahuerta
Juan José Lahuerta Complutense University of Madrid
Joan Bladé
Joan Bladé University of Barcelona
Jesús F. San Miguel
Jesús F. San Miguel University of Navarra
Maria-Victoria Mateos
Maria-Victoria Mateos University of Salamanca
Norbert Schmitz
Norbert Schmitz University of Münster
Albert Oriol
Albert Oriol Autonomous University of Barcelona
Arnon Nagler
Arnon Nagler Sheba Medical Center
Dietger Niederwieser
Dietger Niederwieser Leipzig University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As the demand for qualified healthcare professionals continues to grow, online degree programs provide flexible pathways into the medical field. Prospective students interested in studying medicine in the USA can explore a range of related online degrees that are both accessible and affordable.

For those aiming to become advanced practice nurses, there are cheap online fnp programs that combine quality education with cost-effectiveness. Additionally, prospective registered nurses or students seeking to advance from an associate to a bachelor’s degree can consider online nursing programs and the cheapest online rn to bsn programs to further their careers.

For nurses aspiring to reach leadership, research, or academic roles, the cheapest phd nursing programs online offer flexible options that allow continued employment while advancing academically. These pathways not only make career progression more accessible, but they also help address healthcare workforce shortages nationwide.

Best Scientists Citing Anna Sureda

Trending Scientists

Recently Published Articles